Inhibition Studies on Carbonic Anhydrase Isoforms I, II, IX, and XII with a Series of Sulfaguanidines.
carbonic anhydrase
inhibitors
secondary sulfonamides
sulfaguanidines
tumor-related isoforms
Journal
ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013
Informations de publication
Date de publication:
14 03 2023
14 03 2023
Historique:
revised:
16
01
2023
received:
01
12
2022
pubmed:
25
1
2023
medline:
17
3
2023
entrez:
24
1
2023
Statut:
ppublish
Résumé
Two novel sulfaguanidine series, six N-(N,N'-dialkyl/dibenzyl-carbamimidoyl) benzenesulfonamide derivatives and nine N-(N-alkyl/benzyl-carbamimidoyl) benzenesulfonamide derivatives, were obtained by desulfidative amination of easily accessible dimethyl arylsulfonylcarbonimidodithioates under catalyst- and base-free conditions. The newly synthesized compounds were tested for the inhibition of four different isozymes of human carbonic anhydrase (hCA I, II, IX and XII, EC 4.2.1.1). Both series reported here were inactive against the off-target isozymes hCA I and II (K
Identifiants
pubmed: 36691902
doi: 10.1002/cmdc.202200658
doi:
Substances chimiques
Carbonic Anhydrase I
EC 4.2.1.-
Carbonic Anhydrase IX
EC 4.2.1.1
Sulfaguanidine
15XQ8043FN
Isoenzymes
0
Carbonic Anhydrase Inhibitors
0
Carbonic Anhydrases
EC 4.2.1.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e202200658Informations de copyright
© 2023 Wiley-VCH GmbH.
Références
J. V. Moroney, Y. Ma, W. D. Frey, K. A. Fusilier, T. T. Pham, T. A. Simms, R. J. DiMario, J. Yang, B. Mukherjee, Photosynth. Res. 2011, 109, 133-149;
A. Nocentini, C. T. Supuran, C. Capasso, J. Enzyme Inhib. Med. Chem. 2021, 36, 1988-1995.
C. T. Supuran, Biochem. J. 2016, 473, 2023-2032.
M. I. Hassan, B. Shajee, A. Waheed, F. Ahmad, W. S. Sly, Bioorg. Med. Chem. 2013, 21, 1570-1582.
E. Langella, A. Di Fiore, V. Alterio, S. M. Monti, G. De Simone, K. D'Ambrosio, Int. J. Mol. Sci. 2022, 23, 12045;
B. Z. Kurt, F. Sönmez, Ç. Bilen, A. Ergun, N. Gençer, O. Arslan, M. Kucukislamoglu, J. Enzyme Inhib. Med. Chem. 2016, 31, 991-998.
C. T. Supuran, Expert Opin. Invest. Drugs 2018,27, 963-970;
C. T. Supuran, Expert Opin. Invest. Drugs 2021, 30, 1197-1208;
C. T. Supuran, Metabolites. 2018, 8, 25.
C. T. Supuran, Nat. Rev. Drug Discovery 2008, 7, 168-181.
P. C. McDonald, S. C. Chafe, C. T. Supuran, S. Dedhar, Cancers (Basel). 2022, 14, 3297.
F. Carta, C. T. Supuran, A. Scozzafava, Future Med. Chem. 2014, 6, 1149-1165;
S. Kılıcaslan, M. Arslan, Z. Ruya, Ç. Bilen, A. Ergün, N. Gençer, O. Arslan, J. Enzyme Inhib. Med. Chem. 2016, 31, 1300-1305.
J. Moeker, T. S. Peat, L. F. Bornaghi, D. Vullo, C. T. Supuran, S. A. Poulsen, J. Med. Chem. 2014, 57, 3522-3531;
M. D'Ascenzio, P. Guglielmi, S. Carradori, D. Secci, R. Florio, A. Mollica, M. Ceruso, A. Akdemir, A. P. Sobolev, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2017, 32, 51-59;
J. Ivanova, F. Carta, D. Vullo, J. Leitans, A. Kazaks, K. Tars, R. Žalubovskis, C. T. Supuran, Bioorg. Med. Chem. 2017, 25, 3583-3589.
M. Abdoli, A. Angeli, M. Bozdag, F. Carta, A. Kakanejadifard, H. Saeidian, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2017, 32, 1071-1078;
M. Abdoli, M. Bozdag, A. Angeli, C. T. Supuran, Metabolites. 2018, 8, 37;
M. Abdoli, S. Giovannuzzi, C. T. Supuran, R. Žalubovskis, J. Enzyme Inhib. Med. Chem. 2022, 37, 1568-1576;
M, Abdoli, A. Bonardi, C. T. Supuran, R. Žalubovskis, J. Enzyme Inhib. Med. Chem. 2023, 38, 156-165;
J. Ivanova, M. Abdoli, A. Nocentini, R. Žalubovskis, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2023, 38, 225-238;
M. Abdoli, V. De Luca, C. Capasso, C. T. Supuran, R. Žalubovskis, Int. J. Mol. Sci. 2022, 23, 14115.
L. Puccetti, G. Fasolis, D. Vullo, Z. H. Chohan, A. Scozzafava, C. T. Supuran, Bioorg. Med. Chem. Lett. 2005, 15, 3096-3101.
A. van Loevezijn, J. Venhorst, W. I. Iwema Bakker, C. G. de Korte, W. de Looff, S. Verhoog, J. W. van Wees, M. van Hoeve, R. P. van de Woestijne, M. A. van der Neut, A. J. Borst, J. Med. Chem. 2011, 54, 7030-7054.
S. Carradori, D. Secci, C. D Monte, A. Mollica, M. Ceruso, A. Akdemir, A. P. Sobolev, R. Codispoti, F. De Cosmi, P. Guglielmi, C. T. Supuran, Bioorg. Med. Chem. 2016, 24, 1095-1105;
B. Cornelio, M. Laronze-Cochard, R. Miambo, M. De Grandis, R. Riccioni, B. Borisova, D. Dontchev, C. Machado, M. Ceruso, A. Fontana, C. T. Supuran, Eur. J. Med. Chem. 2019, 175, 40-48.
R. G. Khalifah, J. Biol. Chem. 1971, 246, 2561-2573.
A. B. Vermelho, V. da Silva Cardoso, E. Ricci Junior, E. P. Dos Santos, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2018,33, 139-146;
A. Nocentini, F. Carta, M. Tanc, S. Selleri, C. T. Supuran, C. Bazzicalupi, P. Gratteri, Eur. J. Chem. 2018, 24, 7840-7844;
A. Pustenko, A. Nocentini, P. Gratteri, A. Bonardi, I. Vozny, R. Žalubovskis, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2020, 35, 1011-1020;
A. Nocentini, A. Bonardi, P. Gratteri, B. Cerra, A. Gioiello, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2018, 33, 1453-1459;
Z. H. Chohan, A. Munawar, C. T. Supuran, Met.-Based Drugs 2001, 8, 137-143.
J. Ivanova, F. Carta, D. Vullo, J. Leitans, A. Kazaks, K. Tars, R. Žalubovskis, C. T. Supuran, Bioorg. Med. Chem. 2017, 25, 3583-3589;
F. Briganti, R. Pierattelli, A. Scozzafava, C. T. Supuran, Eur. J. Med. Chem. 1996, 31, 1001-1010;
S. Pastorekova, A. Casini, A. Scozzafava, D. Vullo, J. Pastorek, C. T. Supuran, Bioorg. Med. Chem. Lett. 2004, 14, 869-873;
F. Carta, C. T. Supuran, A. Scozzafava, Future Med. Chem. 2014, 6, 1149-1165;
A. Yıldırım, U. Atmaca, A. Keskin, M. Topal, M. Celik, İ. Gülçin, C. T. Supuran, Bioorg. Med. Chem. 2015, 23, 2598-2605;
A. Innocenti, İ. Gülçin, A. Scozzafava, C. T. Supuran, Bioorg. Med. Chem. Lett. 2010, 20, 5050-5053.